FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 18 USDMF, 13 CEP/COS, 6 JDMF, 1 EU WC, 3 KDMF, 14 NDC API, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

32 Drugs in Development

32 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

260 FDF Dossiers, 134 FDA Orange Book, 99 Europe, 15 Canada, 2 South Africa, 10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML), INJECTABLE;INJECTION - EQ 150MG BASE/ML, SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - EQ 1% BASE, GEL;TOPICAL - EQ 1% BASE, GEL;TOPICAL - 5%;1.2%, GEL;TOPICAL - 5%;EQ 1% BASE, SUPPOSITORY;VAGINAL - 100MG, GEL;TOPICAL - EQ 1% BASE, CREAM;VAGINAL - EQ 2% BASE, AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 3 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Kirsch Pharma, 8 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 1 BioSpectra, 2 CD Formulation, 1 Clariant, 6 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 1 Kerry, 5 Lubrizol Life Science Health, 4 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 16 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Topical, 27 Thickeners and Stabilizers, 27 Parenteral, 25 Solubilizers, 16 Emulsifying Agents, 16 Film Formers & Plasticizers, 13 Fillers, Diluents & Binders, 9 Surfactant & Foaming Agents, 7 Controlled & Modified Release, 7 Rheology Modifiers, 7 Coating Systems & Additives, 7 Direct Compression, 6 Lubricants & Glidants, 5 Taste Masking, 4 Granulation, 3 Chewable & Orodispersible Aids, 3 Co-Processed Excipients, 3 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 58 News #PharmaBuzz

GLOBAL SALES INFORMATION

29 US Medicaid Prescriptions, 8 Regulatory FDF Prices

MARKET PLACE

36 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
29/01/2026	ACS DOBFAR SPA	Italy	ACS Dobfar S.p.A	52946-0603	Clindamycin Phosphate	2009-12-09	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)
29/01/2026	Galenova	Canada	Galenova Inc	79572-007	CLINDAMYCIN PHOSPHATE	2021-05-01	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER

CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers

18 USDMF

13 CEP/COS

6 JDMF

1 EU WC

3 KDMF

14 NDC API

19 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

32 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

260 FDF Dossiers

134 FDA Orange Book

99 Europe

15 Canada

2 South Africa

10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)

INJECTABLE;INJECTION - EQ 150MG BASE/ML

SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - EQ 1% BASE

GEL;TOPICAL - EQ 1% BASE

GEL;TOPICAL - 5%;1.2%

GEL;TOPICAL - 5%;EQ 1% BASE

SUPPOSITORY;VAGINAL - 100MG

GEL;TOPICAL - EQ 1% BASE

CREAM;VAGINAL - EQ 2% BASE

AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

3 SPI Pharma

5 DKSH

1 Pharm-RX Chemical

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Pfanstiehl

6 Kirsch Pharma

8 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

13 BASF

1 BioSpectra

2 CD Formulation

1 Clariant

6 Corel Pharma Chem

1 Esteem Industries

2 Finar

7 Gangwal Chemicals

1 Kerry

5 Lubrizol Life Science Health

4 Microlex e.U

1 Nanjing Bold Chemical

2 Pluviaendo

16 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Topical

27 Thickeners and Stabilizers

27 Parenteral

25 Solubilizers

16 Emulsifying Agents

16 Film Formers & Plasticizers

13 Fillers, Diluents & Binders

SOLUTION;TOPICAL - EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons